The current stock price of NIVF is 0.66 USD. In the past month the price decreased by -54.36%. In the past year, price decreased by -99.96%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.7 | 101.78B | ||
| CI | THE CIGNA GROUP | 10.02 | 76.03B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 134.38 | 24.72B | ||
| LH | LABCORP HOLDINGS INC | 16.39 | 21.49B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.41 | 19.99B | ||
| GH | GUARDANT HEALTH INC | N/A | 14.11B | ||
| DVA | DAVITA INC | 12.31 | 8.02B | ||
| HIMS | HIMS & HERS HEALTH INC | 63.93 | 7.86B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 39.76 | 7.31B | ||
| CHE | CHEMED CORP | 19.95 | 6.22B | ||
| RDNT | RADNET INC | 203.18 | 5.96B | ||
| OPCH | OPTION CARE HEALTH INC | 22 | 5.20B |
NewGenIvf Group Ltd is a TH-based company operating in Health Care Providers & Services industry. The company is headquartered in Bangkok, Bangkok Metropolis and currently employs 76 full-time employees. The company went IPO on 2022-02-15. NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. The company specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. The company has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
NEWGENIVF GROUP LTD-A
13/F, Ps Tower, Sukhumvit 21 Rd (Asoke)
Bangkok BANGKOK METROPOLIS TH
Employees: 76
Phone: 6568185796
NewGenIvf Group Ltd is a TH-based company operating in Health Care Providers & Services industry. The company is headquartered in Bangkok, Bangkok Metropolis and currently employs 76 full-time employees. The company went IPO on 2022-02-15. NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. The company specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. The company has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.
The current stock price of NIVF is 0.66 USD. The price decreased by -2.94% in the last trading session.
NIVF does not pay a dividend.
NIVF has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
null analysts have analysed NIVF and the average price target is 76.5 USD. This implies a price increase of 11490.91% is expected in the next year compared to the current price of 0.66.
You can find the ownership structure of NEWGENIVF GROUP LTD-A (NIVF) on the Ownership tab.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
null analysts have analysed NIVF and the average price target is 76.5 USD. This implies a price increase of 11490.91% is expected in the next year compared to the current price of 0.66.